Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 21, 2022
Diversity and Clonality of T Cell Receptor Repertoire and Antigen Specificities in Small Joints of Early Rheumatoid Arthritis
Sara Turcinov, Erik Af Klint, Bertrand Van Schoubroeck, et al.
Science Immunology
|
April 17, 2021
The shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCR
Jia Jia Lim, Claerwen M Jones, Tiing Jen Loh, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 28, 2014
Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases
Jenny H Xie, Aaron P Yamniuk, Virna Borowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies
Steven N Quayle, Natasha Girgis, Dharma R Thapa, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 21, 2022
Diversity and Clonality of T Cell Receptor Repertoire and Antigen Specificities in Small Joints of Early Rheumatoid Arthritis
Sara Turcinov, Erik Af Klint, Bertrand Van Schoubroeck, et al.
Science Immunology
|
April 17, 2021
The shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCR
Jia Jia Lim, Claerwen M Jones, Tiing Jen Loh, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 28, 2014
Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases
Jenny H Xie, Aaron P Yamniuk, Virna Borowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies
Steven N Quayle, Natasha Girgis, Dharma R Thapa, et al.
Page
of 4